Janda Kim 4
4 · Sorrento Therapeutics, Inc. · Filed Aug 14, 2020
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Award
Stock Options
2020-08-07+150,000→ 150,000 totalExercise: $14.42Exp: 2030-08-07→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]1/48th of the original number of shares subject to this option shall vest and become exercisable on September 7, 2020, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.